# SRX Global (SRXH) — News

SRXH · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/srxh/news

## Recent headlines

- [SRX Global commits $2.5 million to launch multi-strategy trading platform in partnership with 5T Trading, powered by the EMJX platform](https://www.ainvest.com/news/srx-global-commits-2-5-million-launch-multi-strategy-trading-platform-partnership-5t-trading-powered-emjx-platform-2610) — AInvest Wire, Oct 8, 2026
- [SRX Global - Cero 1236, SPV to raise capital without diluting SRX Global shareholders](https://www.ainvest.com/news/srx-global-cero-1236-spv-raise-capital-diluting-srx-global-shareholders-2610) — AInvest Wire, Oct 7, 2026
  SRX Global has announced the formation of Cero 1236, a special purpose vehicle (SPV), to raise capital without diluting the company’s existing shareholders. This strategic move aims to provide the firm with additional financial flexibility while preserving the ownership structure for current…
- [SRX Global - Acquisition expected to accelerate development of cer-1236 for hematologic malignancies](https://www.ainvest.com/news/srx-global-acquisition-expected-accelerate-development-cer-1236-hematologic-malignancies-2610) — AInvest Wire, Oct 7, 2026
  SRX Global has announced an acquisition expected to expedite the development of cer-1236, a therapeutic candidate targeting hematologic malignancies. The move aligns with the company’s strategy to enhance its pipeline through strategic partnerships and targeted acquisitions. While specific terms of…
- [SRX Global - Andrew Kucharchuk expected to serve as president of Cero Therapeutics](https://www.ainvest.com/news/srx-global-andrew-kucharchuk-expected-serve-president-cero-therapeutics-2610) — AInvest Wire, Oct 7, 2026
- [Srx Global - To buy all outstanding stock of Cero Therapeutics, - SEC filing](https://www.ainvest.com/news/srx-global-buy-outstanding-stock-cero-therapeutics-sec-filing-2610) — AInvest Wire, Oct 7, 2026
  SRX Global Inc. (NYSE American: SRXH) has announced its acquisition of senior secured debt in CERo Therapeutics Holdings, Inc. (OTCQB: CERO), an immunotherapy company focused on engineered T cell therapeutics for cancer treatment. This investment is intended to provide CERo with additional capital…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).